The Prevalence of Thyroid Dysfunction and Autoimmunity in Women With History of Miscarriage or Subfertility.

OBJECTIVE To describe the prevalence of and factors associated with different thyroid dysfunction phenotypes in women who are asymptomatic preconception. DESIGN Observational cohort study. SETTING A total of 49 hospitals across the United Kingdom between 2011 and 2016. PARTICIPANTS Women aged 16 to 41years with history of miscarriage or subfertility trying for a pregnancy. METHODS Prevalences and 95% confidence intervals (CIs) were estimated using the binomial exact method. Multivariate logistic regression analyses were conducted to identify risk factors for thyroid disease. INTERVENTION None. MAIN OUTCOME MEASURE Rates of thyroid dysfunction. RESULTS Thyroid function and thyroid peroxidase antibody (TPOAb) data were available for 19213 and 19237 women, respectively. The prevalence of abnormal thyroid function was 4.8% (95% CI, 4.5-5.1); euthyroidism was defined as levels of thyroid-stimulating hormone (TSH) of 0.44 to 4.50 mIU/L and free thyroxine (fT4) of 10 to 21 pmol/L. Overt hypothyroidism (TSH > 4.50 mIU/L, fT4 < 10 pmol/L) was present in 0.2% of women (95% CI, 0.1-0.3) and overt hyperthyroidism (TSH < 0.44 mIU/L, fT4 > 21 pmol/L) was present in 0.3% (95% CI, 0.2-0.3). The prevalence of subclinical hypothyroidism (SCH) using an upper TSH concentration of 4.50 mIU/L was 2.4% (95% CI, 2.1-2.6). Lowering the upper TSH to 2.50 mIU/L resulted in higher rates of SCH, 19.9% (95% CI, 19.3-20.5). Multiple regression analyses showed increased odds of SCH (TSH > 4.50 mIU/L) with body mass index (BMI) ≥ 35.0 kg/m2 (adjusted odds ratio [aOR] 1.71; 95% CI, 1.13-2.57; P = 0.01) and Asian ethnicity (aOR 1.76; 95% CI, 1.31-2.37; P < 0.001), and increased odds of SCH (TSH ≥ 2.50 mIU/L) with subfertility (aOR 1.16; 95% CI, 1.04-1.29; P = 0.008). TPOAb positivity was prevalent in 9.5% of women (95% CI, 9.1-9.9). CONCLUSIONS The prevalence of undiagnosed overt thyroid disease is low. SCH and TPOAb are common, particularly in women with higher BMI or of Asian ethnicity. A TSH cutoff of 2.50 mIU/L to define SCH results in a significant proportion of women potentially requiring levothyroxine treatment.

[1]  A. Coomarasamy,et al.  The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom , 2019, Endocrine Abstracts.

[2]  D. Jurkovic,et al.  Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception , 2019, The New England journal of medicine.

[3]  O. Christiansen,et al.  ESHRE guideline: recurrent pregnancy loss , 2018, Human reproduction open.

[4]  V. Montori,et al.  Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment , 2017, British Medical Journal.

[5]  S. Mandel,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[6]  M. Vanderpump,et al.  Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee , 2016, Clinical endocrinology.

[7]  S. Wessely.  In the novelist ’ s chair Book Physician turned , 2016 .

[8]  J. Kvetny,et al.  Impaired Fertility Associated with Subclinical Hypothyroidism and Thyroid Autoimmunity: The Danish General Suburban Population Study , 2015, Journal of pregnancy.

[9]  F. Azizi,et al.  Thyroid dysfunction and pregnancy outcomes , 2015, Iranian journal of reproductive medicine.

[10]  M. Rayman,et al.  A review of the iodine status of UK pregnant women and its implications for the offspring , 2015, Environmental Geochemistry and Health.

[11]  S. Wessely.  Subclinical hypothyroidism in the infertile female population: a guideline. , 2023, Fertility and sterility.

[12]  R. Negro,et al.  2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children , 2014, European Thyroid Journal.

[13]  G. Brabant,et al.  2013 ETA Guideline: Management of Subclinical Hypothyroidism , 2013, European Thyroid Journal.

[14]  A. Hofman,et al.  Ethnic differences in maternal thyroid parameters during pregnancy: the Generation R study. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[16]  S. Mandel,et al.  Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  J. Franklyn,et al.  Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence , 2011, BMJ : British Medical Journal.

[18]  J. V. D. van der Post,et al.  Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. , 2011, Human reproduction update.

[19]  R. Earl,et al.  Interventions for preventing and treating hyperthyroidism in pregnancy. , 2010, The Cochrane database of systematic reviews.

[20]  M. Surks,et al.  Age- and race-based serum thyrotropin reference limits. , 2010, The Journal of clinical endocrinology and metabolism.

[21]  P. Otero,et al.  Subclinical hypothyroidism and thyroid autoimmunity in women with infertility , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[22]  D. Dazzi,et al.  Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: The role of autoimmunity and thyroid function , 2007, Journal of endocrinological investigation.

[23]  D. Dazzi,et al.  Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[25]  D. Glinoer,et al.  The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. , 2000, Thyroid : official journal of the American Thyroid Association.

[26]  D. Zimmerman.  Fetal and neonatal hyperthyroidism. , 1999, Thyroid : official journal of the American Thyroid Association.

[27]  D. Glinoer,et al.  Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. , 1991, The Journal of clinical endocrinology and metabolism.